References
- Aley, K.O., Reichling, D.B., and Levine, J.D., 1996. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience, 73 (1), 259–265.
- Authier, N., et al., 2003. A new animal model of vincristine-induced nociceptive peripheral neuropathy. NeuroToxicology, 24 (6), 797–805.
- Cahill, C.M. and Coderre, T.J., 2002. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain, 95 (3), 277–285.
- Chiba, T., et al., 2016. Paclitaxel-induced peripheral neuropathy increases substance P release in rat spinal cord. European Journal of Pharmacology, 770, 46–51.
- Chiba, T., et al., 2017. Vincristine-induced peripheral neuropathic pain and expression of transient receptor potential vanilloid 1 in rat. Journal of Pharmacological Sciences, 133 (4), 254–260.
- Geis, C., et al., 2011. Lacosamide has protective disease modifying properties in experimental vincristine neuropathy. Neuropharmacology, 61 (4), 600–607.
- Gong, S.S., et al., 2016. Neuroprotective effect of matrine in mouse model of vincristine-induced neuropathic pain. Neurochemical Research, 41 (11), 3147–3159.
- Ji, X.T., et al., 2013. Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model. PLoS One, 8 (4), e60733.
- Kamei, J., Nozaki, C., and Saitoh, A., 2006. Effect of mexiletine on vincristine-induced painful neuropathy in mice. European Journal of Pharmacology, 536 (1-2), 123–127. https://doi.org/10.1016/j.ejphar.2006.02.033
- Khalilzadeh, M., et al., 2018. The protective effects of sumatriptan on vincristine-induced peripheral neuropathy in a rat model. NeuroToxicology, 67, 279–286.
- Ma, W. and Eisenach, J.C., 2003. Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, calcitonin gene-related peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation. Neuroscience, 121 (3), 681–690.
- McCarthy, P. W., and Lawson, S. N., 1989. Cell type and conduction velocity of rat primary sensory neurons with substance P-like immunoreactivity. Neuroscience, 28 (3), 745–753. 2469036. DOI:https://doi.org/10.1016/0306-4522(89)90019-5
- Mora, E., et al., 2016. Vincristine-induced peripheral neuropathy in pediatric cancer patients. American Journal of Cancer Research, 6 (11), 2416-2430.
- Regoli, D., et al., 1989. Receptors for substance P and related neurokinins. Pharmacology, 38 (1), 1–15.
- Schappacher, K.A., Styczynski, L., and Baccei, M.L., 2017. Early life vincristine exposure evokes mechanical pain hypersensitivity in the developing rat. Pain, 158 (9), 1647–1655.
- Silva, A., et al., 2006. Evidence for direct axonal toxicity in vincristine neuropathy. Journal of the Peripheral Nervous System, 11 (3), 211–216.
- Sweitzer, S.M., Pahl, J.L., and DeLeo, J.A., 2006. Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat. Neuroscience Letters, 400 (3), 258–261.
- Tanner, K.D., et al., 2003. Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience, 118 (3), 809–817.
- Tatsushima, Y., et al., 2011. Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin. Journal of Pharmacology and Experimental Therapeutics, 337 (1), 226–235.
- Vachon, P., Massé, R., and Gibbs, B.F., 2004. Substance P and neurotensin are up-regulated in the lumbar spinal cord of animals with neuropathic pain. Canadian Journal of Veterinary Research, 68 (2), 86–92.
- Weng, H.R., Cordella, J.V., and Dougherty, P.M., 2003. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain, 103 (1), 131–138.
- Xu, J., et al., 2016. EXPRESS: methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn. Molecular Pain, 12.